Journal article · 2017 · Open access
Future research priorities for morbidity control of lymphedema
Indian Journal of Dermatology, 62(1), 33 · Published 1 January 2017 · DOI 10.4103/0019-5154.198039
In brief
“Future research priorities for morbidity control of lymphedema” is a 2017 journal article by Saravu Rama Bhat Narahari and 11 co-authors, published in Indian Journal of Dermatology. OpenAlex counts 10 citations as of 22 November 2026. It is open access under a CC BY-NC-SA licence: the full text is free to read at Indian Journal of Dermatology.
- Citations
- 10
- Most cited in
- 2026 (3)
- Field-weighted impact
- 0.61
- References
- 19
- Authors
- 12
Abstract
BACKGROUND: Innovation in the treatment of lower extremity lymphedema has received low priority from the governments and pharmaceutical industry. Advancing lymphedema is irreversible and initiates fibrosis in the dermis, reactive changes in the epidermis and subcutis. Most medical treatments offered for lymphedema are either too demanding with a less than satisfactory response or patients have low concordance due to complex schedules. A priority setting partnership (PSP) was established to decide on the future priorities in lymphedema research. METHODS: A table of abstracts following a literature search was published in workshop website. Stake holders were requested to upload their priorities. Their questions were listed, randomized, and sent to lymphologists for ranking. High ranked ten research priorities, obtained through median score, were presented in final prioritization work shop attended by invited stake holders. A free medical camp was organized during workshop to understand patients' priorities. RESULTS: One hundred research priorities were selected from priorities uploaded to website. Ten priorities were short listed through a peer review process involving 12 lymphologists, for final discussion. They were related to simplification of integrative treatment for lymphedema, cellular changes in lymphedema and mechanisms of its reversal, eliminating bacterial entry lesions to reduce cellulitis episodes, exploring evidence for therapies in traditional medicine, improving patient concordance to compression therapy, epidemiology of lymphatic filariasis (LF), and economic benefit of integrative treatments of lymphedema. CONCLUSION: A robust research priority setting process, organized as described in James Lind Alliance guidebook, identified seven priority areas to achieve effective morbidity control of lymphedema including LF. All stake holders including Department of Health Research, Government of India, participated in the PSP.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Narahari, S. R. B., Aggithaya, M. G., Moffatt, C. J., Ryan, T., Keeley, V. L., Vijaya, B., Rajendran, R., Karalam, S., Rajagopala, S., Kumar, N., Bose, K. S., & Sushma, K. (2017). Future research priorities for morbidity control of lymphedema. Indian Journal of Dermatology, 62(1), 33. https://doi.org/10.4103/0019-5154.198039
MLA 9
Narahari, Saravu Rama Bhat, et al. “Future research priorities for morbidity control of lymphedema.” Indian Journal of Dermatology, vol. 62, no. 1, 2017, p. 33. https://doi.org/10.4103/0019-5154.198039.
Chicago
Narahari, Saravu Rama Bhat, Madhur Guruprasad Aggithaya, Christine Joy Moffatt, TJ Ryan, Vaughan L Keeley, B Vijaya, R. Rajendran, et al. 2017. “Future research priorities for morbidity control of lymphedema.” Indian Journal of Dermatology 62 (1): 33. https://doi.org/10.4103/0019-5154.198039.
Harvard
Narahari, S. R. B. et al. (2017) ‘Future research priorities for morbidity control of lymphedema’, Indian Journal of Dermatology, 62(1), p. 33. doi:10.4103/0019-5154.198039.
IEEE
S. R. B. Narahari et al., “Future research priorities for morbidity control of lymphedema,” Indian Journal of Dermatology, vol. 62, no. 1, p. 33, 2017, doi: 10.4103/0019-5154.198039.
BibTeX
@article{narahari2017future,
title = {{Future research priorities for morbidity control of lymphedema}},
author = {Narahari, Saravu Rama Bhat and Aggithaya, Madhur Guruprasad and Moffatt, Christine Joy and Ryan, TJ and Keeley, Vaughan L and Vijaya, B and Rajendran, R. and Karalam, SB and Rajagopala, S and Kumar, NK and Bose, K. S. and Sushma, KV},
journal = {Indian Journal of Dermatology},
year = {2017},
volume = {62},
number = {1},
pages = {33},
doi = {10.4103/0019-5154.198039},
url = {https://doi.org/10.4103/0019-5154.198039}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2017 | 1 | |
| 2018 | 1 | |
| 2019 | 1 | |
| 2020 | 2 | |
| 2021 | 1 | |
| 2023 | 1 | |
| 2026 | 3 |
Its field-weighted citation impact is 0.61: it has been cited 0.61 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- lymphedema
- research prioritization
- priority setting partnership
- James Lind Alliance
- lower limb lymphedema
- lymphatic filariasis
- compression therapy
- patient concordance
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Narahari, S. R. B., Aggithaya, M. G., Moffatt, C. J., Ryan, T., Keeley, V. L., Vijaya, B., Rajendran, R., Karalam, S., Rajagopala, S., Kumar, N., Bose, K. S., & Sushma, K. (2017). Future research priorities for morbidity control of lymphedema. Indian Journal of Dermatology, 62(1), 33. https://doi.org/10.4103/0019-5154.198039
How many times has this paper been cited?
10 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Indian Journal of Dermatology: sign in and open the full text from this page.
Who wrote this paper?
Saravu Rama Bhat Narahari, Madhur Guruprasad Aggithaya, Christine Joy Moffatt, TJ Ryan, Vaughan L Keeley, B Vijaya, R. Rajendran, SB Karalam, S Rajagopala, NK Kumar, K. S. Bose, KV Sushma.
What is the DOI of this paper?
10.4103/0019-5154.198039, permanently at https://doi.org/10.4103/0019-5154.198039. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.